Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.

scientific article

Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/MOLECULES21111457
P932PMC publication ID6274223
P698PubMed publication ID27809255

P2093author name stringYun Sun
Jianlong Li
Xiang Fan
Yanfa Meng
Yao Meng
Fenghui Sun
Minlu Wu
P2860cites workDiscontinuous native protein gel electrophoresis.Q50475605
Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity.Q54271750
Protein measurement with the Folin phenol reagentQ20900776
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
A new age for biomedical applications of Ribosome Inactivating Proteins (RIPs): from bioconjugate to nanoconstructsQ26738670
Site-Specific PEGylation of Therapeutic ProteinsQ26777819
Ribosome-inactivating proteins: from plant defense to tumor attackQ26828935
Current status and prospects of polyethyleneglycol-modified medicinesQ26860827
MAP 30: a new inhibitor of HIV-1 infection and replicationQ28323531
Ribosome-inactivating proteins from plants: present status and future prospectsQ29301419
Continuous mode of operation for large volume dosing in analytical carrier ampholyte-free isoelectric focusing of proteins applied to off-line detection of fractionsQ33254627
Current status of ribosome inactivating proteins.Q34029984
Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycolQ34339370
Purification and identification of trichloroethylene induced proteins from Stenotrophomonas maltophilia PM102 by immuno-affinity-chromatography and MALDI-TOF Mass spectrometryQ34761570
A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L.Q35202997
Enzymatic properties of ribosome-inactivating proteins (RIPs) and related toxinsQ36798511
Ribosome inactivating proteins from plants inhibiting virusesQ37967462
Cytotoxicity mechanism of α-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activationQ38766455
Ribosome Inactivating Proteins from Rosaceae.Q39458591
Immunoaffinity purification of α-momorcharin from bitter melon seeds (Momordica charantia).Q39459008
PEGylation of alpha-momorcharin: synthesis and characterization of novel anti-tumor conjugates with therapeutic potentialQ39726241
Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycolQ39804190
Effect of separation dimensions on resolution and throughput using very narrow-range IEF for 2-DE after solution phase isoelectric fractionation of a complex proteomeQ39870482
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectMomordica charantiaQ428750
P577publication date2016-10-31
P1433published inMoleculesQ151332
P1476titleMono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity
P478volume21

Reverse relations

cites work (P2860)
Q60045968Chemosynthesis and characterization of site-specific N-terminally PEGylated Alpha-momorcharin as apotential agent
Q48275920Effectiveness of Antihyperglycemic Effect of Momordica charantia: Implication of T-Cell Cytokines
Q90394569Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties
Q40091791Evidence of Immunosuppressive and Th2 Immune Polarizing Effects of Antidiabetic Momordica charantia Fruit Juice
Q52725563MAP30 promotes apoptosis of U251 and U87 cells by suppressing the LGR5 and Wnt/β-catenin signaling pathway, and enhancing Smac expression.
Q101137934Preparation, Characterization and Pharmacokinetic study of N-Terminal PEGylated D-form Antimicrobial Peptide OM19r-8
Q47574242Special Issue: Ribosome-Inactivating Proteins-Commemorative Issue in Honor of Professor Fiorenzo Stirpe.

Search more.